• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To register, simply click the Register button at the top right.

Large grant awarded to Griffith CFS researcher


iherb 10% discount code OPA989,
australia (brisbane)

Providing increased services for Chronic Fatigue Syndrome sufferers will be the focus of Griffith research following the award of a $1.85m grant to one of Australia’s foremost authorities on the condition.

Professor Sonya Marshall-Gradisnik from theNational Centre For Neuroimmunology and Emerging Diseases (NCNED) at Griffith University was awarded the research grant from the Stafford Fox Medical Research Foundation as part of her team’s bid to accelerate the diagnosis and implementation of appropriate treatment.

Otherwise known as Myalgic Encephalomyelitis (ME), CFS is a highly debilitating disorder characterised by profound fatigue, muscle and joint pain, cerebral symptoms of impaired memory and concentration, impaired cardiovascular function, gut disorder and sensory dysfunction such as noise intolerance and balance disturbance.

Many cases can continue for months or years. It is believed to affect around 460,000 Australians.

In July this year, the NCNED launched a new CFS/ME specialised clinic and smartphone app, both aimed to help patients manage their illness and improve health outcomes.

The clinic is now working in conjunction with patients’ existing GPs to provide individualised care to patients. “I am overwhelmed to receive such as large grant,” says Professor Sonya Marshall-Gradisnik. “This acknowledges the immense research and clinical capabilities at Griffith of our CFS clinicians which is done in collaboration with the Centers for Disease Control and Prevention in the US.

Further enhanced assessment

“The grant will go a long way to providing further enhanced immunological, genetic and neurological assessment of our patients.” “Knowledge generated by these studies will be of great assistance in the management of patients with CFS and will also help CFS patients understand the biological basis of their disease,” says Pro Vice Chancellor (Health) Professor Allan Cripps, a co-investigator on the research team.

Other co-investigators on the team include Professor Donald Staines, Dr Ekua Brenu, Dr Leighton Brandenand Dr Sandra Ramos.

Battery Muncher

Senior Member
Is anyone able to offer a brief summary of research findings from Griffith University? Just wondering what sort of ideas they have...


คภภเє ɠรค๓թєl
Is anyone able to offer a brief summary of research findings from Griffith University? Just wondering what sort of ideas they have...

they publish some immune studies, some papers discussing inclusion criteria (and how Oxford and self-report are unreliable)

they set up a van to go to severe patients' homes and draw blood for studies so homebound/bedbound people with ME could be included (very super impressed, many gold stars for this)

This team is maybe the first to use ICC in research. Along with some others, they've been using CCC for a while now.

If you like to listen rather than read, you can find some podcasts. If you prefer to read, there are some print articles like the one in the OP.